CORPORATE SOCIAL RESPONSIBILITY

Corporate Social Responsibility

Our commitment to patients and healthcare professionals extends beyond our efforts to research and develop quality medications. Once a medication is approved, we focus on providing information on safe prescribing practices, responsible use, storage, and disposal of those medications and other medications in the same therapeutic class.

We do more than develop medications. Each year we demonstrate our commitment to the communities we serve through partnerships, grants, and volunteerism. Being a responsible corporate citizen is a priority for us and our efforts are focused on:

  • Helping to address the opioid addiction crisis
  • Supporting responsible use of controlled substances
  • Supporting wellness and economic development efforts in the communities where we live and work

Community engagement is supported through healthcare, education, and economic development grants and programs. In the past year, we have supported our communities through the following efforts:

  • Subsidizing a local school lunch program
  • Hosting local school supply drives
  • Remodeling a local classroom
  • Participating in a national blood drive
  • Providing pandemic flu kits to a national service organization
  • Collecting supplies and preparing meals for local organizations that support homeless communities
  • Supporting local economic development efforts
  • Providing in-kind donations to a local domestic violence crisis center, a hospice house, a community college, and a mental health recovery center

For close to two decades, Purdue has engaged in over 60 distinct initiatives to stem prescription opioid abuse in close collaboration with states, communities, industry partners, and law enforcement agencies. These initiatives have focused on:

  • Recovery to work models
  • Neonatal abstinence syndrome research and support
  • Recovery peer support programs
  • Measurable prevention education
  • Medication-assisted therapy availability in emergency departments
  • Overdose reversal and harm reduction
  • Supporting efforts to reduce prescription drug diversion through Prescription Drug Monitoring Program improvements and integrations
  • Increasing awareness of prescription drug take-back programs and publishing results from a survey study on this topic

For information on grants and giving, please click here.

For specific inquiries or feedback about our CSR efforts, reach out to us at csr@pharma.com.